NsP Sv. Jakuba Bardejov n.o.

The Pneumology Department is strongly focused on respiratory diseases, especially asthma, chronic obstructive pulmonary disease (COPD), chronic bronchitis, and refractory chronic cough. These studies are designed to assess new treatment approaches and improve control of symptoms, exacerbations, and long-term outcomes.

• Testing combination and add-on therapies to better prevent severe outcomes in COPD
• Evaluating treatments aimed at reducing exacerbations in chronic obstructive pulmonary disease
• Studying new options for refractory and unexplained chronic cough
• Assessing therapies for uncontrolled moderate to severe eosinophilic asthma

This area reflects a clear effort to improve both daily symptom relief and broader disease management for people living with chronic lung conditions.

The site also supports research in immune-mediated disease, with a particular interest in asthma and related inflammatory airway conditions. The trials are centered on improving disease control and exploring whether new therapies can reduce flare-ups and treatment burden.

• Investigating treatments for moderate to severe eosinophilic asthma
• Exploring add-on therapies for better control of airway inflammation
• Evaluating rescue-treatment strategies that may improve safety and effectiveness

This research helps clarify how emerging therapies may support patients whose symptoms remain difficult to manage with standard care.

Clinical research at this institution includes cancer studies, particularly in colorectal cancer with cancer cachexia and advanced or metastatic non-small cell lung cancer. The main goal is to evaluate new approaches that may improve treatment benefit, support patient condition, and address complications linked to advanced disease.

• Studying supportive care approaches for cancer cachexia
• Assessing potential new therapies for colorectal cancer
• Comparing a pembrolizumab biosimilar with established immunotherapy in non-small cell lung cancer

This work combines oncology and supportive care research, aiming to improve both disease management and quality of life for patients with serious cancers.

The research portfolio also includes studies in metabolic and nutritional disorders, especially where weight loss and reduced physical resilience affect cancer care. These trials are focused on understanding whether new treatments can help restore body weight and improve tolerance to illness.

• Evaluating therapy for cancer cachexia and weight loss
• Assessing safety and tolerability of a treatment intended to support nutritional status
• Exploring ways to improve outcomes in patients with advanced cancer and metabolic decline

At Sv. Jakuba 21 in Bardejov, this line of research complements the site’s respiratory and oncology work by addressing the broader physical impact of serious disease.